Outcomes of immune tolerance induction with rituximab to eradicate high-titer inhibitor of hemophilia A: depicted by exponential decay model and the gene expression profile of different outcomes by RNA-sequencing.
Saved in:
| Title: | Outcomes of immune tolerance induction with rituximab to eradicate high-titer inhibitor of hemophilia A: depicted by exponential decay model and the gene expression profile of different outcomes by RNA-sequencing. |
|---|---|
| Authors: | Li Z; Hemophilia Comprehensive Care Center, Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China., Tang Y; State Key Laboratory of Multimodal Artificial Intelligence Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, China., Chen Z; Hematologic Disease Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China., Liu G; Hemophilia Comprehensive Care Center, Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China., Yao W; Hemophilia Comprehensive Care Center, Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China., Li G; Hematologic Disease Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China., Cheng X; Department of Pharmacy, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China., Peng Y; Center for Clinical Epidemiology and Evidence-based Medicine, Capital Medical University, Beijing, China., Cai S; Center for Clinical Epidemiology and Evidence-based Medicine, Capital Medical University, Beijing, China., Cui C; State Key Laboratory of Multimodal Artificial Intelligence Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, China., Ai D; Hemophilia Comprehensive Care Center, Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China; Pediatrics Departments, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China., Zhang J; Hemophilia Comprehensive Care Center, Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China; Pediatrics Departments, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China., Poon MC; Departments of Medicine, Pediatrics and Oncology, University of Calgary Cumming School of Medicine, Calgary, Canada., Zhang W; State Key Laboratory of Multimodal Artificial Intelligence Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, China. Electronic address: zhangwenshengia@hotmail.com., Wu R; Hemophilia Comprehensive Care Center, Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China. Electronic address: runhuiwu@hotmail.com. |
| Source: | Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2025 Aug; Vol. 23 (8), pp. 2436-2448. Date of Electronic Publication: 2025 Apr 24. |
| Publication Type: | Clinical Trial, Phase IV; Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836 (Electronic) Linking ISSN: 15387836 NLM ISO Abbreviation: J Thromb Haemost Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40286913 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Outcomes of immune tolerance induction with rituximab to eradicate high-titer inhibitor of hemophilia A: depicted by exponential decay model and the gene expression profile of different outcomes by RNA-sequencing. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Li+Z%22">Li Z</searchLink>; Hemophilia Comprehensive Care Center, Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Tang+Y%22">Tang Y</searchLink>; State Key Laboratory of Multimodal Artificial Intelligence Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Chen+Z%22">Chen Z</searchLink>; Hematologic Disease Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Liu+G%22">Liu G</searchLink>; Hemophilia Comprehensive Care Center, Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Yao+W%22">Yao W</searchLink>; Hemophilia Comprehensive Care Center, Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Li+G%22">Li G</searchLink>; Hematologic Disease Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Cheng+X%22">Cheng X</searchLink>; Department of Pharmacy, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Peng+Y%22">Peng Y</searchLink>; Center for Clinical Epidemiology and Evidence-based Medicine, Capital Medical University, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Cai+S%22">Cai S</searchLink>; Center for Clinical Epidemiology and Evidence-based Medicine, Capital Medical University, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Cui+C%22">Cui C</searchLink>; State Key Laboratory of Multimodal Artificial Intelligence Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Ai+D%22">Ai D</searchLink>; Hemophilia Comprehensive Care Center, Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China; Pediatrics Departments, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Hemophilia Comprehensive Care Center, Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China; Pediatrics Departments, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Poon+MC%22">Poon MC</searchLink>; Departments of Medicine, Pediatrics and Oncology, University of Calgary Cumming School of Medicine, Calgary, Canada.<br /><searchLink fieldCode="AU" term="%22Zhang+W%22">Zhang W</searchLink>; State Key Laboratory of Multimodal Artificial Intelligence Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, China. Electronic address: zhangwenshengia@hotmail.com.<br /><searchLink fieldCode="AU" term="%22Wu+R%22">Wu R</searchLink>; Hemophilia Comprehensive Care Center, Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China. Electronic address: runhuiwu@hotmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101170508%22">Journal of thrombosis and haemostasis : JTH</searchLink> [J Thromb Haemost] 2025 Aug; Vol. 23 (8), pp. 2436-2448. <i>Date of Electronic Publication: </i>2025 Apr 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase IV; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101170508 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-7836 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215387836%22">15387836 </searchLink><i>NLM ISO Abbreviation: </i>J Thromb Haemost <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40286913 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jtha.2025.04.015 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2436 Titles: – TitleFull: Outcomes of immune tolerance induction with rituximab to eradicate high-titer inhibitor of hemophilia A: depicted by exponential decay model and the gene expression profile of different outcomes by RNA-sequencing. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li Z – PersonEntity: Name: NameFull: Tang Y – PersonEntity: Name: NameFull: Chen Z – PersonEntity: Name: NameFull: Liu G – PersonEntity: Name: NameFull: Yao W – PersonEntity: Name: NameFull: Li G – PersonEntity: Name: NameFull: Cheng X – PersonEntity: Name: NameFull: Peng Y – PersonEntity: Name: NameFull: Cai S – PersonEntity: Name: NameFull: Cui C – PersonEntity: Name: NameFull: Ai D – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Poon MC – PersonEntity: Name: NameFull: Zhang W – PersonEntity: Name: NameFull: Wu R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2025 Aug Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1538-7836 Numbering: – Type: volume Value: 23 – Type: issue Value: 8 Titles: – TitleFull: Journal of thrombosis and haemostasis : JTH Type: main |
| ResultId | 1 |
